Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Reactive oxygen species (ROS) and singlet oxygen in lipid compartments refer to highly reactive oxygen-derived molecules, such as singlet molecular oxygen (1O2) and lipid hydroperoxides, that are localized within cellular membranes or lipid droplets. These species are central to the process of lipid peroxidation, a deleterious chain reaction that compromises membrane integrity and generates toxic electrophiles like malondialdehyde (MDA) and 4-hydroxynonenal (4-HNE) (Girotti, 1998, Journal of Lipid Research; Ayala et al., 2014, Oxidative Medicine and Cellular Longevity). In the context of photodynamic therapy (PDT), singlet oxygen is the primary cytotoxic agent generated by light-activated photosensitizers to induce localized tumor cell death (Agostinis et al., 2011, CA: A Cancer Journal for Clinicians). Conversely, the accumulation of these species is a key driver of ferroptosis, a form of regulated cell death implicated in neurodegeneration and ischemia-reperfusion injury (Stockwell et al., 2017, Cell). Therapeutic interventions either aim to produce these species for oncological applications or utilize lipophilic antioxidants, such as alpha-tocopherol or ferrostatin-1, to scavenge them and prevent tissue damage (Traber & Stevens, 2011, Free Radical Biology and Medicine). Consequently, while not a single protein target, the regulation of ROS within lipid environments is a critical therapeutic strategy across oncology and neurology.
Generation of singlet oxygen via Type II photochemical reactions for targeted cell destruction, or scavenging of lipid-localized radicals to inhibit lipid peroxidation and ferroptosis.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Reactive oxygen species and singlet oxygen in lipid compartments.